A technique used to decipher the DNA sequence, called next-generation sequencing (NGS), was successfully used to identify two new mutations…
Diogo Pinto
At Bionews we’re committed to providing the most accurate, relevant, and up-to-date reporting for our patient communities. Our goal is to ensure that everyone has access to disease-specific information that is both trustworthy and easy to understand. You can read more about our editorial policy here.
Articles by Diogo Pinto
A recent study using technology that powers NantOmics‘ comprehensive GPS Cancer test confirmed that chronic inflammation caused by the…
Castle Creek Pharmaceuticals‘ investigational treatment CCP-020 (diacerein 1% ointment) was granted Fast Track designation by the U.S. Food and…
Amryt Pharma’s investigational therapy AP101, designed to reduce the time it takes for skin wounds to close, was…
A gel made from platelets — tiny blood cells involved in blood clotting — collected from umbilical cord blood showed…
Two new potentially damaging mutations were identified in a family with epidermolysis bullosa pruriginosa (EBP), a rare type of epidermolysis…